FORM 3A - Director's/Chief Executive's Notice - Interests in Shares of Listed Corporation
Form Serial No
:
DA20140723000094
1.
Name of listed corporation
:
Luye Pharma Group Ltd.
2.
Stock code
:
02186
3.
Class of shares
:
Ordinary Shares
4.
Number of issued shares in class
:
3,321,073,843
5.
Name of director (English) as printed on HKID/Passport
:
(
Surname
)
Liu
(
Other names
)
Dian Bo
8.
Name of director (Chinese)
:
劉殿波
9.
Chinese Character Code
:
12.
Date of relevant event
:
18/07/2014
(dd/mm/yyyy)
13.
Date when director became aware of the relevant event/ interest in the shares (if later)
:
14.
Details of relevant event
:
Relevant event code describing circumstances
Code describing capacity in which shares were/are held
Number of shares bought/sold or involved
Currency of transaction
On Exchange
Off Exchange
Before relevant event
After relevant event
Highest price per share
Average price per share
Average consideration per share
Consideration code
Long position
122
209
49,820,000
HKD
5.920
301
Short position
132
209
49,820,000
15.
Total shares in listed corporation immediately before the relevant event
:
Total number of shares
Percentage figure (%)
Long Position
1,509,819,930
45.46
Short Position
49,820,000
1.50
16.
Total shares in listed corporation immediately after the relevant event
:
Total number of shares
Percentage figure (%)
Long Position
1,459,999,930
43.96
Short Position
0
0.00
17.
Capacity in which interests disclosed in Box 16 are held (required for Initial Notification only)
:
Code describing capacity
Number of shares
209
Long position
1,459,999,930
18.
Further information in respect of derivative interests in listed corporation
:
Code describing derivatives
Exercise period
Consideration - if derivatives granted by listed corporation
Number of shares
Begins
Ends
Price for grant
Exercise price
Price on assignment
Nil
19.
Further information in relation to interests of children under 18 and/or spouse
:
Name of child/spouse
Number of shares
Nil
20.
Further information in relation to interests of corporations controlled by Director
:
Name of controlled corporation
Address and place of incorporation
Name of controlling shareholder
% control
Direct interest
Number of shares
Shorea LBG
Helvetia Court, South Esplanade, St Peter Port, Guernsey.
Liu Dian Bo
100.00
N
Long position
1,459,999,930
Ginkgo Trust Limited
Helvetia Court, South Esplanade, St Peter Port, Guernsey.
Shorea LBG
100.00
N
Long position
1,459,999,930
Nelumbo Investments Limited
Helvetia Court, South Esplanade, St Peter Port, Guernsey.
Ginkgo Trust Limited
100.00
N
Long position
1,459,999,930
AsiaPharm Holdings Ltd.
Clarendon House, 2 Church Street, Hamilton HM11, Bermuda
Nelumbo Investments Limited
70.00
N
Long position
1,459,999,930
Luye Pharma Holdings Ltd.
Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands
AsiaPharm Holdings Ltd.
100.00
N
Long position
1,459,999,930
Luye Pharmaceutical International Co., Ltd.
PO Box 309, Ugland House, Ground Cayman, KY1-1104, Cayman Islands
Luye Pharma Holdings Ltd.
100.00
N
Long position
1,459,999,930
Luye Pharmaceutical Investment Co., Ltd.
PO Box 309, Ugland House, Ground Cayman, KY1-1104, Cayman Islands
Luye Pharmaceutical International Co., Ltd.
100.00
Y
Long position
1,459,999,930
21.
Further information in relation to interests held by Director jointly with another person
:
Name of joint shareholder
Address
Number of shares
Nil
22.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust
:
Names of Trust
Address
Status code
Number of shares
(Private)
Addresses of individuals are not displayed.
503
Long position
1,459,999,930
23.
Further information from a party to an agreement under Section 317
:
Names of other parties
Address
Number of shares
Nil
Total number of shares in which substantial shareholder is interested under section 317 and 318
:
24.
Date of filing this Form 3A
:
23/07/2014
(dd/mm/yyyy)
26.
Number of attachments
:
0